Follow this page and receive
notifications about new suppliers
Eculizumab API Manufacturers
compare suppliers & get competitive offers
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Follow us
Producer
Produced in:
Established in: 2019
MOQ: 1 g
Employees: 10+
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
+ 0
All certificates
Distributor
Produced in:
Established in: 2005
MOQ: -
Employees: 200+
Portfolio of over 2,000 APIs
Precise quality control
End-to-end global regulatory support
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Eculizumab API 219685-50-4?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Eculizumab. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Eculizumab
- Cas Number:
- 219685-50-4
- DrugBank number:
- DB01257
- Unique Ingredient Identifier:
- A3ULP0F556
About Eculizumab
Learn more about Eculizumab. Eculizumab is a monoclonal antibody that targets complement protein C5 Binding to this protein prevents the activation of a complement terminal complex, which is used to treat a number of autoimmune conditions Eculizumab was granted FDA approval on 16 March 2007.
Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements
Eculizumab is a type of Immunoglobulins
Immunoglobulins are an important subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in the field of immunology and pharmaceutical research. Also known as antibodies, immunoglobulins are proteins produced by the immune system to identify and neutralize foreign substances such as bacteria, viruses, and toxins.
These pharmaceutical APIs are extensively used in the development of various therapeutic products, including vaccines, immunotherapies, and diagnostic reagents. Immunoglobulins can be derived from different sources, such as human plasma, recombinant DNA technology, or hybridoma technology. Human plasma-derived immunoglobulins are obtained from pooled blood donations and undergo a rigorous purification process to ensure their safety and efficacy.
Immunoglobulins exhibit remarkable specificity and binding affinity towards their target antigens, making them ideal candidates for targeted therapies. They can be classified into different types, including IgG, IgM, IgA, IgD, and IgE, each with its unique functions and properties.
In pharmaceutical applications, immunoglobulins are employed for passive immunization, where they provide immediate protection against specific diseases by directly transferring antibodies to individuals. They can also be utilized for the treatment of autoimmune disorders, infectious diseases, and certain types of cancer.
The development and production of immunoglobulin APIs involve stringent quality control measures to ensure batch-to-batch consistency and adherence to regulatory guidelines. These APIs are characterized by various analytical techniques, including chromatography, electrophoresis, and spectroscopy, to assess their purity, potency, and structural integrity.
In summary, immunoglobulins are a vital subcategory of pharmaceutical APIs that hold immense potential for therapeutic and diagnostic applications. Their diverse range of functions and targeted specificity make them indispensable in the field of immunology and pharmaceutical research.
Eculizumab (Immunoglobulins), classified under Immunomodulators
Immunomodulators, a category of pharmaceutical active pharmaceutical ingredients (APIs), are substances that help regulate and modify the immune response of an individual. These compounds play a crucial role in treating various immune-related disorders and diseases. Immunomodulators work by either enhancing or suppressing the immune system, depending on the specific condition being treated.
Immunomodulators are used in the treatment of autoimmune disorders, such as rheumatoid arthritis, multiple sclerosis, and psoriasis. By suppressing the immune system, these APIs help reduce the overactive immune response associated with these conditions, thereby alleviating symptoms and preventing further damage to the body's tissues.
On the other hand, immunomodulators are also employed to boost the immune system in cases of immunodeficiency disorders. These APIs stimulate the immune response, enabling the body to better fight off infections and diseases. Additionally, immunomodulators are utilized in the prevention and treatment of organ transplant rejection, where they help modulate the immune system to accept the transplanted organ.
The development and production of immunomodulators require rigorous testing and quality control to ensure their safety and efficacy. Pharmaceutical companies carefully formulate these APIs into various dosage forms, including tablets, capsules, injections, and topical preparations, to cater to different patient needs.
In summary, immunomodulators form a vital category of pharmaceutical APIs that regulate and modify the immune system. With their ability to modulate immune responses, these compounds contribute significantly to the management and treatment of various immune-related disorders and diseases, improving the quality of life for many patients.
Eculizumab manufacturers | traders | suppliers
We have 2 companies offering Eculizumab produced in 2 different countries.
Get in contact with the supplier of your choice:
- Apino Pharma Co., Ltd. from China, product country of origin China
- LGM Pharma from United States, product country of origin World
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
